Yms Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.61 Cr
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.27 Cr
- Revenue Growth 96.32%
- Profit Growth 65.53%
- Ebitda 24.68%
- Net Worth 5.34%
- Total Assets 31.93%
About Yms Laboratories
Yms Laboratories Private Limited (YLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 March 2011 and has a history of 13 years and 11 months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.61 Cr.
The company currently has active open charges totaling ₹8.27 Cr.
Bangar Kanumuri and Penumatsa Dattatreyavarma serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233TG2011PTC073080
- Company No.
073080
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Yms Laboratories Private Limited offer?
Yms Laboratories Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Chemical Intermediates, Pharma Ingredients & Raw Materials, API Intermediate, Chemical Reagents & Catalysts, Bromine Compound, Nutraceuticals & Dietary Supplements, Nutraceuticals, Industrial Chemicals, Flavours & Aromatics.
Who are the key members and board of directors at Yms Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bangar Kanumuri  | Director | 11-Nov-2013 | Current |
| Penumatsa Dattatreyavarma | Director | 11-Nov-2013 | Current |
Financial Performance of Yms Laboratories.
Yms Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 96.32% increase. The company also saw a substantial improvement in profitability, with a 65.53% increase in profit. The company's net worth moved up by a moderate rise of 5.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yms Laboratories?
In 2022, Yms Laboratories had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹8.27 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 8.14 Cr
- Axis Bank Limited : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Dec 2023 | Axis Bank Limited | ₹1.32 M | Open |
| 12 Sep 2017 | Others | ₹8.14 Cr | Open |
How Many Employees Work at Yms Laboratories?
Yms Laboratories has a workforce of 55 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yms Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yms Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
